RegenLab USA, Inc. cash flow statement RGNA
Annual
Quarterly
No matching figures were found for this statement.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RGNA
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jersey City, NJ
- SEC CIK
- 2084031
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.